Blog
T1International at the United Nations Multi-stakeholder hearing on NCDs and Mental Health
5 May 2025, 7:52 p.m. in News & Statements by T1International
On May 2, 2025, #insulin4all advocates, including T1International’s Executive Director Shaina Kasper, participated in a high-level United Nations hearing to shape the agenda for the upcoming Political Declaration on noncommunicable diseases. In remarks, Kasper called on UN member states to urgently address insulin affordability, support public manufacturing, and center patients in global diabetes policy decisions. Emphasizing that the insulin crisis is far from over, she highlighted patient stories from around the world and urged bold action to ensure equitable access to lifesaving diabetes care. Read more
Progress on Insulin Access: Adding Rapid-Acting Insulin Analogues to the Essential Medicines List
9 Apr 2025, 10:04 p.m. in Global Stories, News & Statements by T1International
T1International’s Impact in 2024
3 Mar 2025, 6:26 p.m. in #insulin4all USA, News & Statements by Melissa Passarelli
U.S. Action 2025: Circus of Pharma Greed!
3 Feb 2025, 11:58 p.m. in #insulin4all USA, News & Statements by T1International
T1International's 2025 Strategic Plan
21 Jan 2025, 7:28 p.m. in News & Statements by T1International
Check out T1International's 2025 blog post Read more
T1International Year in Review: 2024
15 Dec 2024, 11:41 a.m. in #insulin4all USA, Global Stories, News & Statements by T1International
As 2024 comes to an end, we’re taking a moment to reflect on the collective power of the T1International community. This year has been filled with challenges and victories as we’ve worked together to fight for affordable and accessible insulin. Here’s a month-by-month look at what we’ve accomplished, thanks to your support and the dedication of advocates across the globe. Read more
Make it Right: The Fight for Insulin Access on World Diabetes Day
20 Nov 2024, 6:19 p.m. in #insulin4all USA, Global Stories by Shaina Kasper
On World Diabetes Day, we shine a spotlight on a glaring injustice: millions of people with diabetes in low- and middle-income countries are denied access to affordable insulin pens—a delivery method that could save and transform lives. Pharmaceutical giants Eli Lilly, Novo Nordisk, and Sanofi have monopolized the diabetes market, prioritizing profit over people. It’s time to demand change. It’s time to make it right. Read more
Opinion: The insulin crisis is far from over
16 Oct 2024, 6:08 p.m. in #insulin4all USA, News & Statements by Arden Parrish
This blog post was first published in the Hartford Courant on September 15, 2024 by Arden Parrish under the title: Opinion: The insulin crisis is far from over. Public pharma could be the solution. Read more
T1International Announces Leadership Transition: Shaina Kasper Named Executive Director
16 Sep 2024, 10:56 a.m. in News & Statements by T1International
T1International is pleased to announce that Shaina Kasper has been appointed as the new Executive Director. Shaina succeeds Elizabeth “Liz” Pfiester, the organization’s Founder and Executive Director since 2013, who established T1International as a force for change in the fight against insulin price gouging and for the rights of people living with type 1 diabetes. Read more
Facing My Guilt: I am surviving, but diabetics in Gaza are not
19 Aug 2024, 8 p.m. in Global Stories by Ali Hisham
Ten years ago, when I was first diagnosed with type one diabetes, I spent countless hours studying my newly diagnosed condition. I came across a research paper by Stanford University stating that people living with type 1 diabetes make around 180 more decisions per day than people without diabetes, with a rate of an extra decision every 5 minutes of waking time. I then realised that type 1 diabetes is a full-time job, without vacations or time off. Read more